Results 181 to 190 of about 138,553 (254)

Evaluation of Resistance in Bt Maize Event DBN3601T Expressing Cry1Ab and Vip3Aa Proteins Against <i>Athetis lepigone</i> (Möschler) in North China. [PDF]

Plants (Basel)
Zhang Z, Gong Z, Kang G, Yang X, Hou Y, Wu K.   +5 more
europepmc   +1 more source

Duck Orbivirus and Egg Production: A Newly Identified Duck Orbivirus Is the Etiological Agent of Egg Production Decline in Chinese Breeder Ducks

Animal Research and One Health, EarlyView.
Field samples from breeder duck farms with egg‐production decline were subjected to viral detection, genome sequencing, and virus isolation. Experimental infection demonstrated that duck orbivirus (DORV) causes a significant and persistent reduction in egg production in breeder ducks.
Bing Li, Jianhua Wang, Xuezhi Cui, Xinxing Chu, You Wang, Dongmin Hao, Mingqing Xu, Haixia Chang, Huihui Li, Mingtian Mao, Mian Wu, Chengguang Lu, Jing Tang, Suyun Liang, Zhanbao Guo, Zhengkui Zhou, Youxiang Diao, Shuisheng Hou, Yi Tang   +18 more
wiley   +1 more source

Phytochemical Profile and Insecticidal Potential of Two Halophytes, Atriplex halimus and Suaeda fruticosa, Against Tribolium confusum: In Vitro and In Silico Approaches. [PDF]

Chem Biodivers
Tabouri M, Djellouli M, Belkheir K, Benotmane K, Dahoun M, Mohammed AS, Nemmiche S, Bendif H, Alsalamah SA, Elfalleh W, Boufahja F, Moscoso-Ruiz I, Cea-Pavez I, Verardo V, Garzoli S.   +14 more
europepmc   +1 more source

Adverse immunostimulation in early phase clinical trials: Key findings and recommendations based on the investigator's clinical experience

British Journal of Clinical Pharmacology, EarlyView.
Problem setting The emergence of therapeutic proteins has coincided with an increase of acute adverse immunostimulation (AIS). AIS has occured in clinical trials despite compliance with regulatory guidelines on preclinical evaluation and its incidence is anticipated to increase even further.
Juliette A. van den Noort, Marella C. E. van Ruissen, Lisanne C. A. Smidt, Naomi B. Klarenbeek, Philip H. K. Kremer, Manon A. A. Jansen, Jacobus Burggraaf, Joop M. A. van Gerven, Matthijs Moerland   +8 more
wiley   +1 more source

Biotic interactions biogeography: A framework for understanding how species interactions shape biodiversity patterns across scales. [PDF]

PLoS Biol
Galiana N, Araújo MB.
europepmc   +1 more source

What Makes an “Ideal” Cell Line for Recombinant Adeno‐Associated Virus Production?

Biotechnology and Bioengineering, EarlyView.
Several host cell types have been used to produce rAAVs to date. Cell line‐specific traits that are beneficial in the context of rAAV manufacturing are reviewed here, with the goal of developing a consensus on the ‘ideal’ characteristics that an rAAV production host should possess (created with Biorender.com).
James Conheady, Nicholas Donohue, Alexandra Bogdanovic, Sharon Davin, Brian Glennon, Niall Barron, C. Mark Smales   +6 more
wiley   +1 more source

Expected Liking of and Emotional Responses to Alternative Protein Burger Patties Among a Convenience Sample of UK Meat Eaters. [PDF]

Foods
Zhang Y, Thibodeau M, Ford R, Yang Q.
europepmc   +1 more source

Glycoengineered Recombinant Alpha1‐Antitrypsin Results in Comparable In Vitro and In Vivo Activities to Human Plasma‐Derived Protein

Biotechnology and Bioengineering, EarlyView.
ABSTRACT Alpha‐1‐antitrypsin (A1AT) is a multifunctional, clinically important, high‐value therapeutic glycoprotein that can be used for the treatment of many diseases, such as A1AT deficiency, diabetes, graft‐versus‐host disease, cystic fibrosis, and various viral infections. Currently, the only U.S. food and drug administration‐approved treatment for
Frances Rocamora, Chen‐Lin Hsieh, Sanne Schoffelen, Johnny Arnsdorf, Eric A. Toth, Abdul S. Yunus, Thomas E. Cleveland IV, Sara Petersen Bjørn, Mina Ying Min Wu, Noel G. McElvaney, Bjørn Gunnar Rude Voldborg, Thomas R. Fuerst, Nathan E. Lewis   +12 more
wiley   +1 more source

Integrating image-based phenotyping and GWAS to map resistance to spittlebug nymphs in interspecific Urochloa grasses. [PDF]

G3 (Bethesda)
Espitia-Buitrago P, Perea C, Mejia-Medina JC, Hernández LM, Castiblanco V, Ryan C, De Vega JJ, Jauregui RN.   +7 more
europepmc   +1 more source